The first comprehensive guidelines dedicated to minimizing infections in patients undergoing surgeries and procedures ...

In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and publishe ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

Integrating lifestyle care into low back pain management resulted in greater improvements in disability, weight loss and ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain.Journavx received FDA ...

As opioid pain medications continue being prescribed for chronic and severe pain, understanding their risks becomes ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...

First Pediatric Guideline ... Advanced Pain Management Using AI for Drug Discovery Oct. 4, 2024 — An estimated one in five Americans live with chronic pain and current treatment options leave ...